Benzinga | Jul 26, 2021 04:33PM EDT

Agile Therapeutics Q2 EPS $(0.20) Beats $(0.21) Estimate; Total Prescriptions Up 171%

Agile Therapeutics (NASDAQ:AGRX) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.21) by 4.76 percent. This is a 66.67 percent decrease over losses of $(0.12) per share from the same period last year.